Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Langer

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
Klinische Padiatrie|May 14, 2009
Health-related quality of life (HRQL) in all-patients treated with chemotherapy only: a report from the late effects surveillance system in GermanyJ Peeters, J Meitert, M Paulides, et al.
Der Urologe. Ausg. A|September 28, 2004
[Bioartificial materials in urology]K Sternberg, C Selent, N Hakansson, et al.
Medical and Pediatric Oncology|July 13, 2002
Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOHM Marx, T Langer, N Graf, et al.
Klinische Padiatrie|October 26, 2013
YouTube as a source of information for children with paroxysmal episodesP Borusiak, T Langer, D Tibussek, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 9, 2025
Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory IssuesStephan von Haehling, Henning T Langer, Steven B Heymsfield, et al.
The Journal of Biological Chemistry|April 26, 1996
Substitution of PIM1 protease in mitochondria by Escherichia coli Lon proteaseU Teichmann, L van Dyck, B Guiard, et al.
Journal of Cancer Research and Clinical Oncology|October 6, 2005
Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS)W Stöhr, M Paulides, I Brecht, et al.
Oncology Reports|September 18, 2004
Hearing function in soft tissue sarcoma patients after treatment with carboplatin: a report from the Late Effects Surveillance SystemW Stöhr, T Langer, A Kremers, et al.
Cancer Investigation|June 11, 2005
Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance systemW Stöhr, T Langer, A Kremers, et al.
Klinische Padiatrie|April 29, 2005
Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS)T Langer, W Stöhr, M Paulides, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Klinische Padiatrie|May 14, 2009
Health-related quality of life (HRQL) in all-patients treated with chemotherapy only: a report from the late effects surveillance system in GermanyJ Peeters, J Meitert, M Paulides, et al.
Der Urologe. Ausg. A|September 28, 2004
[Bioartificial materials in urology]K Sternberg, C Selent, N Hakansson, et al.
Medical and Pediatric Oncology|July 13, 2002
Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOHM Marx, T Langer, N Graf, et al.
Klinische Padiatrie|October 26, 2013
YouTube as a source of information for children with paroxysmal episodesP Borusiak, T Langer, D Tibussek, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 9, 2025
Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory IssuesStephan von Haehling, Henning T Langer, Steven B Heymsfield, et al.
The Journal of Biological Chemistry|April 26, 1996
Substitution of PIM1 protease in mitochondria by Escherichia coli Lon proteaseU Teichmann, L van Dyck, B Guiard, et al.
Journal of Cancer Research and Clinical Oncology|October 6, 2005
Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS)W Stöhr, M Paulides, I Brecht, et al.
Oncology Reports|September 18, 2004
Hearing function in soft tissue sarcoma patients after treatment with carboplatin: a report from the Late Effects Surveillance SystemW Stöhr, T Langer, A Kremers, et al.
Cancer Investigation|June 11, 2005
Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance systemW Stöhr, T Langer, A Kremers, et al.
Klinische Padiatrie|April 29, 2005
Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS)T Langer, W Stöhr, M Paulides, et al.
Pageof 19